Close×

Amcor has added new, more sustainable High Shield laminates to its pharmaceutical packaging portfolio, which will initially be introduced into the European market.

According to Amcor, the new low carbon, recycle-ready packaging options deliver on two fronts, providing the high barrier and performance requirements needed for the industry, while supporting pharmaceutical companies’ recyclability agendas.

These new High Shield laminates include a more sustainable pharmaceutical sachet, stickpack and strippack packaging, providing options in both paper-based and polyolefin-based materials.

Amcor says that global sales of pharmaceutical products, which many of these products rely on for their packaging, is anticipated to reach $1.4 trillion by 2026, with the European market expected to grow 5.4 per cent through 2028.

The more sustainable High Shield Pharma Laminates options for pharmaceutical sachet, stickpack and strippack packaging will first be introduced throughout Europe to help meet this growing demand and to address the sustainability requirements established by the European Union and regional governments.

Amcor says the High Shield’s “innovative material structure” enables recycle-readiness in line with regional demands and supports the market differentiation efforts of pharmaceutical companies; and will allow manufacturers and packers to leverage existing filling machines, with no required investments or efficiency losses.

“Amcor’s addition of more sustainable High Shield Pharma Laminates in its portfolio demonstrate our unwavering commitment to innovation for the healthcare industry, as well as our promise to the environment,” said Virginie Maes, vice president, Healthcare for Amcor Flexibles EMEA. “To Amcor, nothing is more important in our healthcare packaging than delivering the safety and efficacy needed for medicine and medical devices that millions of people rely on every day.”

Late last year, Amcor opened a new ISO certified medical packaging facility for the Asia Pacific region in Singapore which the company says is designed for healthcare industry needs for quality and regulatory compliance, and has the capacity for growth to support medical-device manufacturers.

Food & Drink Business

It has been 20 years since SPC was listed on the Australian Securities Exchange (ASX) but this week returned as SPC Global (ASX: SPG) following its merger with The Original Juice Company (OJC) and Nature One Dairy (NOD).

New Zealand Infant formula brand, LittleOak, is boosting its retail presence through a new partnership with Independent Pharmacies Australia (IPA) that will see its range available in IPA’s banner group, Chemist Discount Centre (CDC).

Fonterra says a plan to convert two coal boilers to wood pellets at its Clandeboye site in South Canterbury, New Zealand, is a crucial step in its commitment to exit coal by 2037.